Achieve Life Sciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.13
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.13
|
-1.35
|
-0.22
|
-19.47%
|
|
2022-06-30
|
-0.83
|
-1.08
|
-0.25
|
-30.12%
|
|
2022-03-31
|
-0.81
|
-0.80
|
0.01
|
1.23%
|
|
2021-12-31
|
-0.69
|
-0.76
|
-0.07
|
-10.14%
|
|
2021-09-30
|
-1.11
|
-0.71
|
0.40
|
36.04%
|
|
2021-06-30
|
-1.22
|
-1.53
|
-0.31
|
-25.41%
|
|
2021-03-31
|
-1.03
|
-1.30
|
-0.27
|
-26.21%
|
|
2020-12-31
|
-1.25
|
-1.11
|
0.14
|
11.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.23
|
|
2021-12-31
|
-4.30
|
|
2020-12-31
|
-6.13
|
|
2019-12-31
|
-42.60
|
|
2018-12-31
|
-39.03
|
|
2017-12-31
|
-184.03
|
|
2016-12-31
|
-474.10
|
|
2015-12-31
|
-0.68
|
|
2014-12-31
|
-117.10
|
|
2013-12-31
|
-237.60
|
|
2012-12-31
|
-180.40
|
|
2011-12-31
|
-265.10
|
|
2010-12-31
|
-202.40
|
|
2009-12-31
|
-111.10
|
|
2008-12-31
|
65.10
|
|
2007-12-31
|
-39.60
|
|
2006-12-31
|
-73.70
|
|
2005-12-31
|
-97.90
|
|
2004-12-31
|
-7526.92
|
|
2003-12-31
|
-75.90
|
|
2002-12-31
|
-94.60
|
|
2001-12-31
|
-10080.47
|
|
1999-12-31
|
62.70
|
|
1998-12-31
|
-15120.61
|
|
1997-12-31
|
-23.10
|
|
1996-12-31
|
-42.90
|
|
1995-12-31
|
-44.00
|